Xiang Xiao

Liver tumour immune microenvironment subtypes and neutrophil heterogeneity

Ruidong Xue, Qiming Zhang, Qi Cao et al. · Nature · 2022 · 895 citations

Hepatology, Liver Physiology, Hepatobiliary Tumor +9

A phase II study of modified FOLFOX as first-line chemotherapy in advanced small bowel adenocarcinoma

Xiang Xiao, Ya Wen Liu, Ling Zhang et al. · Anti-Cancer Drugs · 2012 · 107 citations

Modified Folfox, Gastrointestinal Oncology, Folfox Regimen +15

Hedgehog signaling promotes sorafenib resistance in hepatocellular carcinoma patient-derived organoids

Siqi Wang, Yang Wang, Xiaodong Xun et al. · Journal of Experimental & Clinical Cancer Research · 2020 · 107 citations · Full text

Tumor stage and primary treatment of hepatocellular carcinoma at a large tertiary hospital in China: A real-world study

Jian‐Hong Zhong, Ning‐Fu Peng, Xue‐Mei You et al. · Oncotarget · 2017 · 87 citations · Full text

Transarterial chemoembolization versus best supportive care for patients with hepatocellular carcinoma with portal vein tumor thrombus：a multicenter study

Xiang Xiao, W. Y. Lau, Zhenyu Wu et al. · European Journal of Surgical Oncology · 2019 · 68 citations

Surgical Oncology, Venous Thrombosis, Hepatology +10